Correction: Su et al. NADPH Oxidase Subunit CYBB Confers Chemotherapy and Ferroptosis Resistance in Mesenchymal Glioblastoma via Nrf2/SOD2 Modulation. Int. J. Mol. Sci. 2023, 24, 7706

I-Chang Su; Yu-Kai Su; Syahru Agung Setiawan; Vijesh Kumar Yadav; Iat-Hang Fong; Chi-Tai Yeh; Chien-Min Lin; Heng-Wei Liu

doi:10.3390/ijms26104837

Correction: Su et al. NADPH Oxidase Subunit CYBB Confers Chemotherapy and Ferroptosis Resistance in Mesenchymal Glioblastoma via Nrf2/SOD2 Modulation. Int. J. Mol. Sci. 2023, 24, 7706

Int J Mol Sci. 2025 May 19;26(10):4837. doi: 10.3390/ijms26104837.

Authors

I-Chang Su^{1

2

3

4}, Yu-Kai Su^{1

2

3

4}, Syahru Agung Setiawan^{5

6}, Vijesh Kumar Yadav⁶, Iat-Hang Fong^{1

2

3

4}, Chi-Tai Yeh^{6

7}, Chien-Min Lin^{1

2

3

4}, Heng-Wei Liu^{1

2

3

4}

Affiliations

¹ Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei City 11031, Taiwan.
² Department of Neurology, School of Medicine, College of Medicine, Taipei Medical University, Taipei City 11031, Taiwan.
³ Division of Neurosurgery, Department of Surgery, Taipei Medical University-Shuang Ho Hospital, New Taipei City 23561, Taiwan.
⁴ Taipei Neuroscience Institute, Taipei Medical University, Taipei City 11031, Taiwan.
⁵ International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei City 11031, Taiwan.
⁶ Department of Medical Research & Education, Taipei Medical University-Shuang Ho Hospital, New Taipei City 23561, Taiwan.
⁷ Continuing Education Program of Food Biotechnology Applications, College of Science and Engineering, National Taitung University, Taitung 95092, Taiwan.

Abstract

In the original publication [...].

Publication types

Published Erratum